In many cancer types, OCTN2 expression is upregulated and exerts tumor-promoting effects by facilitating carnitine uptake, which fuels mitochondrial fatty acid β-oxidation and provides alternative energy sources [29,30]. This evidence concerns the gene SLC22A5 and cancer.